Bittium Biosignals extends supply agreement with Preventice Solutions for ECG monitoring devices

Bittium Biosignals, a subsidiary of Bittium Corporation, signed an extension agreement with Preventice Solutions (a Boston Scientific subsidiary) to supply BodyGuardian MINI ECG monitoring devices. The agreement is valued at approximately USD 40-45 million, with revenues accruing from 2022 to 2025.

“We are happy to strengthen this strategic relationship with this agreement.”news.cision.com

• 1 source
• news.cision.comBittium Corporation's subsidiary Bittium Biosignals Ltd and Preventice Solutions have signed an extension agreement for the supply of ECG monitoring devices - Bittium OyjFeb 2, 2022

Summarized from public sources; check the original articles before acting on it.